SCHEMBL5683299

SCHEMBL5683299

O=CC(CC(=O)O)NS(=O)(=O)c1cccc2ccccc12

nearest known ligand 0.82

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 9/20 0.82
SLC1A3 P43003 1/20 0.54
SLC1A2 P43004 1/20 0.54
SLC1A1 P43005 1/20 0.54
TSHR P16473 1/20 0.47
F2 P00734 1/20 0.44
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
PRSS3 P35030 1/20 0.44
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43
HCRTR1 O43613 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HTT P42858 1/20 0.43
PFKFB3 Q16875 1/20 0.43
HDAC1 Q13547 1/20 0.42
MCL1 Q07820 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5681184 0.90 CASP1 (1.00) CASP1SLC1A3SLC1A2SLC1A1TSHR
SCHEMBL8520124 0.86 CASP1 (0.91) CASP1SLC1A3SLC1A2SLC1A1TSHR
SCHEMBL8684370 0.81 SLC1A3 (0.60) CASP1SLC1A3SLC1A2SLC1A1TSHR
SCHEMBL5682798 0.80 CASP1 (0.63) CASP1
SCHEMBL2202179 0.80 ATM (0.58) CASP1SLC1A3SLC1A2SLC1A1TSHR
SCHEMBL9154395 0.79 SLC1A3 (0.54) CASP1SLC1A3SLC1A2SLC1A1TSHR
SCHEMBL5680762 0.79 CASP1 (0.66) CASP1SLC1A3SLC1A2SLC1A1ALDH1A1
SCHEMBL5680759 0.78 CASP1 (0.65) CASP1ALDH1A1
SCHEMBL5683133 0.78 CASP1 (0.65) CASP1
SCHEMBL5681240 0.78 CASP1 (1.00) CASP1SLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0932600-B1 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1BETA CONVERTING ENZYME INHIBITORS WARNER LAMBERT CO (US) 2006-02-08 EP claimed
US-6083981-A USEFUL FOR TREATMENT OF STROKE, INFLAMMATORY DISEASES, SEPTIC SHOCK, REPERFUSION INJURY, ALZHEIMER'S DISEASE, SHIGELLOSIS WARNER-LAMBERT COMPANY (US) 2000-07-04 US claimed
EP-0932600-B1 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1BETA CONVERTING ENZYME INHIBITORS WARNER LAMBERT CO (US) 2006-02-08 EP disclosed
US-6083981-A USEFUL FOR TREATMENT OF STROKE, INFLAMMATORY DISEASES, SEPTIC SHOCK, REPERFUSION INJURY, ALZHEIMER'S DISEASE, SHIGELLOSIS WARNER-LAMBERT COMPANY (US) 2000-07-04 US disclosed
US-6054487-A ADMINISTERING AN INTERLEUKIN-ONE BETA CONVERTING ENZYME SUFFICIENT TO INHIBIT PRODUCTION OF GAMMA-INTERFERON BASF AKTIENGESELLSCHAFT (DE) 2000-04-25 US disclosed